MAXWELL FINLAND, F.A.C.P.; WILLIAM C. SPRING JR.; FRANCIS C. LOWELL
During the past few months, in accord with the general trend in the treatment of bacterial infections, the focus of attention in the literature dealing with the therapy of pneumonia has shifted from specific serums to chemotherapy. This was quite natural and is easy to appreciate in a disease like pneumonia, where specific serotherapy is rather laborious, expensive and subject to a number of important limitations, in contrast to chemotherapy, which is simple to administer, relatively inexpensive and has a wider scope of usefulness. The generally favorable results more or less universally obtained with sulfapyridine have fully justified this shift
FINLAND M, SPRING WC, LOWELL FC. SPECIFIC TREATMENT OF THE PNEUMOCOCCIC PNEUMONIAS; AN ANALYSIS OF THE RESULTS OF SERUM THERAPY AND CHEMOTHERAPY AT THE BOSTON CITY HOSPITAL FROM JULY 1938 THROUGH JUNE 1939(SPECIFIC TREATMENT OF THE PNEUMOCOCCIC PNEUMONIAS; AN ANALYSIS OF THE RESULTS OF SERUM THERAPY AND CHEMOTHERAPY AT THE BOSTON CITY HOSPITAL FROM JULY 1938 THROUGH JUNE 1939*). Ann Intern Med. 1940;13:1567–1593. doi: 10.7326/0003-4819-13-9-1567
Download citation file:
Published: Ann Intern Med. 1940;13(9):1567-1593.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use